Search Results

• • 29,273 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment

  Authors:J M Chessells, G Harrison, S M Richards, C C Bailey, F G H Hill, B E Gibson, et al.From:Archives of Disease in Childhood (Vol. 85, Issue 4) Peer-Reviewed

  Oct. 20013,443 words Article Abstract Aims--To examine the clinical and biological features of acute lymphoblastic leukaemia in children with Down's syndrome (DS), to compare their survival with other children, and to determine if entry to...

• A model of human acute lymphoblastic leukemia in immune-deficient SCID mice

  Authors:Suzanne Kamel-Reid, Michelle Letarte, Christian Sirard, Monica Doedens, Tom Grunberger, Gabrielle Fulop, et al.From:Science (Vol. 246, Issue 4937) Peer-Reviewed

  Dec. 22, 19893,175 words Article Acute lymphoblastic leukemia (ALL) of the non-T type is the most common leukemia in children. A living (in vivo) animal model for studying the growth and progression of ALL was devised using a special strain of mice....

• The 47.sup.th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O010 - O169).

  From:Bone Marrow Transplantation (Vol. 56, Issue Suppl 1) Peer-Reviewed

  June 2021102,305 words Article 1460LAuthor Affiliations: 14 - 17 March, 2021 * Virtual Meeting Copyright: Modified and published with permission from https://www.ebmt.org/annual-meeting Sponsorship Statement: Publication of this supplement is...

• Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy

  Authors:M.V. Stankov, M. El Khatib, B. Kumar Thakur, K. Heitmann, D. Panayotova-Dimitrova, J. Schoening, et al.From:Leukemia (Vol. 28, Issue 3) Peer-Reviewed

  Mar. 20146,477 words Report 1610LHistone deacetylase (HDAC) inhibitors (HDACis) are well-characterized anti-cancer agents with promising results in clinical trials. However, mechanistically little is known regarding their selectivity in killing...

• Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.

  Authors:Shahrzad Zehtab, Mahla Sattarzadeh Bardsiri, Roohollah Mirzaee Khalilabadi, Mohsen Ehsan, and Ahmad FatemiFrom:BMC Research Notes (Vol. 15, Issue 1) Peer-Reviewed

  Feb. 14, 20223,030 words Report 1430LObjective Acute lymphoblastic leukemia (ALL) is one of the most common cancers in children for which the exact pathogenesis is not yet known. Single-nucleotide variants (SNVs) in different DNA repair genes are reported...

• Progress in adult leukemia care

  Authors:Robert P. Gale, Howard Ozer, Alberto Paciucci, and Susan L. BackhusFrom:Patient Care (Vol. 22, Issue 16) Peer-Reviewed

  Oct. 15, 19885,131 words Article The outlook for adults who develop leukemia is improved; but treatment protocols are investigational, and regimens must be individualized. Here is what to expect from your oncologist and how to help....

• The burden and outcomes associated with four leukemias: AML, ALL, CLL and CML

  Authors:Alberto Redaelli, Jennifer M. Stephens, Benjamin L. Laskin, Chris L. Pashos, and Marc F. BottemanFrom:Expert Review of Anticancer Therapy (Vol. 3, Issue 3) Peer-Reviewed

  June 1, 200313,358 words Report 1490LGiven the recent advances in the treatment of hematologic malignancies and the many other treatments on the horizon, physicians and payers will be faced with the critical decisions of when to use new treatments in the...

• Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy

  Authors:C.D. DiNardo, N. Daver, N. Jain, N. Pemmaraju, C. Bueso-Ramos, C.C. Yin, et al.From:Leukemia (Vol. 28, Issue 4) Peer-Reviewed

  May 20142,307 words Letter to the editor 1670LCreated in 2001 and retained in 2008, the World Health Organization (WHO) now recognizes a distinct category of myelodysplastic/myeloproliferative neoplasms (MDS/MPN) for those patients diagnosed with clinical,...

• Philadelphia positive chronic myeloid leukemia mimicking acute lymphoblastic leukemia in a child

  Authors:Kaumudee Pattnaik, Asaranti Kar, Sabita Palai, Bibudhendu Pati, and Chandrasekhar MohapatraFrom:African Journal of Medical and Health Sciences (Vol. 12, Issue 2) Peer-Reviewed

  July-December 20131,882 words Article 1630LByline: Kaumudee. Pattnaik, Asaranti. Kar, Sabita. Palai, Bibudhendu. Pati, Chandrasekhar. Mohapatra Chronic myeloid leukemia (CML) is a rare hematological malignancy in children. The more common acute lymphoblastic...

• Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia

  Authors:M. Blink, T.D. Buitenkamp, M.M. van den Heuvel-Eibrink, A.A. Danen-van Oorschot, V. de Haas, D. Reinhardt, et al.From:Leukemia (Vol. 25, Issue 8) Peer-Reviewed

  Aug. 20112,370 words Letter to the editor 1630LChildren with Down Syndrome (DS) have an increased risk of developing leukemia, including both acute myeloid (ML-DS) and acute lymphoblastic leukemia (DS ALL). (1) These leukemias differ in clinical characteristics and...

• A prospective study on the influence of anti-neoplastic treatment on the immunisation status against haemophilus influenzae B and tetanus in children receiving treatment for acute leukaemia

  Authors:S.R. Patel, P.T. Heath, and M. OrtinFrom:Archives of Disease in Childhood (Vol. 89, Issue 4) Peer-Reviewed

  Apr. 2004236 words Brief article Introduction: New trends for the treatment of childhood acute myeloblastic and lymphoblastic leukaemia (AML, ALL) include more aggressive schedules whose effects on the immunisation status remain unknown. Method: As...

• Childhood leukemia and fallout from the Nevada nuclear tests

  Authors:Charles E. Land, Frank W. Mckay, and Stella G. MachadoFrom:Science (Vol. 223) Peer-Reviewed

  Jan. 13, 19843,437 words Article Childhood Leukemia and Fallout from the Nevada Nuclear Tests In 1979 Lyon et al. (1) reported an association between increased risk of mortality from childhood leukemia and residence in the southern 17 counties of...

• Oxidative stress, motor abilities, And behavioral adjustment in children treated for acute lymphoblastic leukemia

  Authors:Marilyn J. Hockenberry, Kevin R. Krull, Kathleen C. Insel, Lynnette L. Harris, Patricia M. Gundy, Kristin B. Adkins, et al.From:Oncology Nursing Forum (Vol. 42, Issue 5) Peer-Reviewed

  Sept. 20155,399 words Report 1430LPurpose/Objectives: To examine associations among oxidative stress, fine and visual-motor abilities, and behavioral adjustment in children receiving chemotherapy for acute lymphoblastic leukemia (ALL). Design: A...

• GlycoMimetics Announces Publication of Preclinical Data Showing Role of E-selectin Ligands in Multiple Myeloma

  From:Obesity, Fitness & Wellness Week

  May 20, 2017374 words Brief article 1640L2017 MAY 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- GlycoMimetics, Inc. (NASDAQ: GLYC) announced the publication of results from a preclinical study that showed its drug...

• RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib

  Authors:H. Lilljebjorn, H. Agerstam, C. Orsmark-Pietras, M. Rissler, H. Ehrencrona, L. Nilsson, et al.From:Leukemia (Vol. 28, Issue 4) Peer-Reviewed

  May 20141,565 words Letter to the editor 1910LTo date, more than 500 fusion genes have been described in hematological malignancies, yet only a small fraction of these are sufficiently common, and with a known clinical impact, to justify routine clinical analysis....

• Immunological effects of vaccines combined with granulocyte colony-stimulating factor on a murine WEHI-3 leukemia model

  Authors:Jinqiu Chen, Miling Zhang, Fuling Zhou, Jin Wang, Ben Niu, and Wanggang ZhangFrom:Oncology Letters (Vol. 13, Issue 4) Peer-Reviewed

  Apr. 20174,252 words Report 1440LAbstract. Granulocyte colony-stimulating factor (G-CSF) mobilizes regulatory T cells (Tregs) from bone marrow into the peripheral blood, by reducing the expression of stromal cell-derived factor-1[alpha] (SDF-1[alpha])....

• Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia

  Authors:P.Y. Jotta, M.A. Ganazza, A. Silva, M.B. Viana, M.J. da Silva, L.J.G. Zambaldi, et al.From:Leukemia (Vol. 24, Issue 1) Peer-Reviewed

  Jan. 20101,792 words Letter to the editor... 1640LWe have recently shown that constitutive activation of PI3K/Akt signaling pathway is a very common event in pediatric T-cell acute lymphoblastic leukemia (T-ALL) and is critical for leukemic cell viability. PI3K/Akt...

• 5T4 oncofetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype

  Authors:F.V. Castro, O.J. McGinn, S. Krishnan, G. Marinov, J. Li, A.J. Rutkowski, et al.From:Leukemia (Vol. 26, Issue 7) Peer-Reviewed

  July 20126,677 words Report 1880LAlthough the overall prognosis in childhood acute lymphoblastic leukemia (ALL) is good, outcome after relapse is poor. Recurrence is frequently characterized by the occurrence of disease at extramedullary sites, such as...

• Concurrent hairy cell leukemia and chronic lymphocytic leukemia: Diagnostic and therapeutic implications.

  Author:Mahmood Al-MendalawiFrom:Indian Journal of Medical and Paediatric Oncology (Vol. 41, Issue 1) Peer-Reviewed

  Jan-March 2020333 words Letter to the editor... 1500LByline: Mahmood. Al-Mendalawi Sir, In October-December 2018 issue of the Indian Journal of Medical and Paediatric Oncology , Anoop et al .[1] described a case of concurrent hairy cell leukemia (HCL) and chronic...

• Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia

  Authors:M. Paganin, M. Zecca, G. Fabbri, K. Polato, A. Biondi, C. Rizzari, et al.From:Leukemia (Vol. 22, Issue 12) Peer-Reviewed

  Dec. 20085,528 words Clinical report The aim of the study was to analyze the impact of minimal residual disease (MRD) after reinduction therapy on the outcome of children with relapsed 'high-risk' acute lymphoblastic leukemia (ALL). Sixty patients with...